Serum autoantibodies against the dermal-epidermal junction in patients with chronic pruritic disorders, elderly individuals and blood donors prospectively recruited

British Journal of Dermatology

Volumn 170, Issue 4, 2014, Pages 943-947

  Van Beek, N ^a   Dohse, A ^a   Riechert, F ^a   Krull, V ^a   Recke, A ^a   Zillikens, D ^a   Schmidt, E ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; AUTOANTIBODY; COLLAGEN TYPE 7; KALININ; LAMININ GAMMA1; P200 ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ANTIBODY BLOOD LEVEL; ARTICLE; ATOPIC DERMATITIS; BASAL CELL CARCINOMA; BASAL MEMBRANE ZONE; BASEMENT MEMBRANE; BLOOD DONOR; DERMOEPIDERMAL JUNCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; LEG ULCER; MAJOR CLINICAL STUDY; MALE; PAPULAR URTICARIA; PRIORITY JOURNAL; PROSPECTIVE STUDY; PRURITIC SKIN DISORDER; PRURITUS; PSORIASIS; RISK FACTOR; SENESCENCE; SKIN BIOPSY; BLOOD; BULLOUS PEMPHIGOID; CHRONIC DISEASE; EPIDERMIS; IMMUNOHISTOCHEMISTRY; IMMUNOLOGY; MIDDLE AGED;

ADULT; AGED; AUTOANTIBODIES; BASEMENT MEMBRANE; BLOOD DONORS; CHRONIC DISEASE; EPIDERMIS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; PEMPHIGOID, BULLOUS; PROSPECTIVE STUDIES; PRURITUS; RISK FACTORS;

EID: 84929940951     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12739     Document Type: Article

References (20)

1. Langan SM, Smeeth L, Hubbard R, et al,. Bullous pemphigoid and pemphigus vulgaris-incidence and mortality in the UK: population based cohort study. BMJ 2008; 337: 160-3.
2. Joly P, Baricault S, Sparsa A, et al,. Incidence and mortality of bullous pemphigoid in France. J Invest Dermatol 2012; 132: 1998-2004.
3. Schmidt E, Zillikens D,. Pemphigoid diseases. Lancet 2013; 381: 320-32.
4. Jung M, Kippes W, Messer G, et al,. Increased risk of bullous pemphigoid in male and very old patients: a population-based study on incidence. J Am Acad Dermatol 1999; 41: 266-8.
5. Thoma-Uszynski S, Uter W, Schwietzke S, et al,. BP230- and BP180-specific auto-antibodies in bullous pemphigoid. J Invest Dermatol 2004; 122: 1413-22.
6. Hachisuka H, Kurose K, Karashima T, et al,. Serum from normal elderly individuals contains anti-basement membrane zone antibodies. Arch Dermatol 1996; 132: 1201-5.
7. Feliciani C, Caldarola G, Kneisel A, et al,. IgG autoantibody reactivity against bullous pemphigoid (BP) 180 and BP230 in elderly patients with pruritic dermatoses. Br J Dermatol 2009; 161: 306-12.
8. Jedlickova H, Racovska J, Niedermeier A, et al,. Anti-basement membrane zone antibodies in elderly patients with pruritic disorders and diabetes mellitus. Eur J Dermatol 2008; 18: 534-8.
9. Hofmann SC, Otto C, Bruckner-Tuderman L, et al,. Isolated NC16a-ELISA testing is of little value to identify bullous pemphigoid in elderly patients with chronic pruritus. Eur J Dermatol 2009; 19: 634-5.
10. Wieland CN, Comfere NI, Gibson LE, et al,. Anti-bullous pemphigoid 180 and 230 antibodies in a sample of unaffected subjects. Arch Dermatol 2010; 146: 21-5.
11. Foureur N, Mignot S, Senet P, et al,. [Correlation between the presence of type-2 anti-pemphigoid antibodies and dementia in elderly subjects with no clinical signs of pemphigoid]. Ann Dermatol Venereol 2006; 133: 439-43 [Article in French].
12. Ghohestani RF, Nicolas JF, Rousselle P, et al,. Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 1997; 133: 1102-7.
13. Schmidt E, Skrobek C, Kromminga A, et al,. Cicatricial pemphigoid: IgA and IgG autoantibodies target epitopes on both intra- and extracellular domains of bullous pemphigoid antigen 180. Br J Dermatol 2001; 145: 778-83.
14. Zillikens D, Herzele K, Georgi M, et al,. Autoantibodies in a subgroup of patients with linear IgA disease react with the NC16A domain of BP1801. J Invest Dermatol 1999; 113: 947-53.
15. Lazarova Z, Sitaru C, Zillikens D, et al,. Comparative analysis of methods for detection of anti-laminin 5 autoantibodies in patients with anti-epiligrin cicatricial pemphigoid. J Am Acad Dermatol 2004; 51: 886-92.
16. Zillikens D, Kawahara Y, Ishiko A, et al,. A novel subepidermal blistering disease with autoantibodies to a 200-kDa antigen of the basement membrane zone. J Invest Dermatol 1996; 106: 1333-8.
17. van Beek N, Rentzsch K, Probst C, et al,. Serological diagnosis of autoimmune bullous skin diseases: prospective comparison of the BIOCHIP mosaic-based indirect immunofluorescence technique with the conventional multi-step single test strategy. Orphanet J Rare Dis 2012; 7: 49.
18. Widmer R, Ziaja I, Grune T,. Protein oxidation and degradation during aging: role in skin aging and neurodegeneration. Free Radic Res 2006; 40: 1259-68.
19. Di Zenzo G, Thoma-Uszynski S, Calabresi V, et al,. Demonstration of epitope-spreading phenomena in bullous pemphigoid: results of a prospective multicenter study. J Invest Dermatol 2011; 131: 2271-80.
20. Rieckhoff-Cantoni L, Bernard P, Didierjean L, et al,. Frequency of bullous pemphigoid-like antibodies as detected by western immunoblot analysis in pruritic dermatoses. Arch Dermatol 1992; 128: 791-4.